Loading...
FDA Issues Complete Response Letter to Amneal for Parkinson Agent IPX203.
Published Jul 03, 2023 06:53PMIncreased Mortality Risk and Shorter Life Expectancy Associated With Sleeping Pills.
Published Jul 03, 2023 09:06PMCenobamate as a Promising Treatment for Patients With Epilepsy: William E. Rosenfeld, MD, FAAN, FAES.
Published May 03, 2023 05:01PMNeurologyLive® Friday 5 — March 10, 2023.
Published Mar 10, 2023 08:05PMCreating Positive, Helpful Work Environments for Patients With NMOSD: Farrah Mateen, MD, PhD.
Published Mar 08, 2023 02:07PMNeurologyLive® Brain Games: March 5, 2023.
Published Mar 05, 2023 11:09AMNeurologyLive® Friday 5 — March 3, 2023.
Published Mar 03, 2023 08:08PMAccess to MS Care in Underserved and Diverse Populations: Marisa McGinley, DO.
Published Feb 26, 2023 06:07PMOcrelizumab and Rituximab Demonstrate Similar Safety, Efficacy in Treatment of Multiple Sclerosis.
Published Feb 25, 2023 08:02PMSatralizumab Shows Long-term Efficacy and Safety in AQP4-IgG-Seropositive NMOSD.
Published Feb 25, 2023 10:00PMFrom “Diagnose and Adiós” to Brain Health: Are We There Yet?.
Published Feb 25, 2023 04:02PMBTK Inhibitor Evobrutinib Displays Superior Efficacy Compared With Anti-CD20 Treatment for MS.
Published Feb 25, 2023 03:18PMEpisode 83: The ARISE Study and Using DMTs in RIS.
Published Feb 24, 2023 03:00AMClosing Remarks, Research Themes in Stroke From ISC 2023: Tudor Jovin, MD.
Published Feb 15, 2023 08:07PMUnderstanding Nuances of Mobile Stroke Units and When to Transfer Directly to Angiography: Shazam Hussain, MD, FRCP, FAHA.
Published Feb 13, 2023 02:20PMGreater Burden of Care Identified in Caregivers of Patients With Advanced Parkinson Disease.
Published Feb 11, 2023 08:00PMStroke Prevention and Atrial Fibrillation Management, Thoughts From STROKE-AF Study: Lee Shwamm, MD.
Published Feb 10, 2023 06:11PMNeurologyLive® Friday 5 — February 10, 2023.
Published Feb 10, 2023 08:11PMNeuroprotective Effects of ApTOLL, TLR4 Receptor Angatonists to Treat Ischemic Stroke.
Published Feb 11, 2023 04:04PMCombination of Higher Dose ApTOLL and EVT Reduces Mortality and Disability in Ischemic Stroke.
Published Feb 09, 2023 08:07PMThe site is protected by reCAPTCHA
Help neurologylive reach the Founder Status of the WikiXM San Diego News.
https://wikixm.com/register/ d0f3cac4d12fa2668b1ffbc4e3254253
The site is protected by reCAPTCHA
WikiXM use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Read more about cookies here
Introducing Your Local Garage where you can post and sell everything you have wanted to sell.
Post upto 5 items for free. After that it's just $20 a year to post up to 50 items in your own Garage.
Directly Communicate with buyers.
Get direct feedback from Buyers to improve your postings.
Receive updates and reminders on items posted but not sold to improve sales.
Selling analytics
Your Garage will come with more selling features to help you get your items sold fast!
The site is protected by reCAPTCHA
You need to verify your email to proceed
The site is protected by reCAPTCHA
The site is protected by reCAPTCHA
Welcome to WikiXM. Become the voice of your town.
Sign up now
The site is protected by reCAPTCHA
WikiXM is a local news platform that brings local news back to your town. WikiXM is where users can create, discuss and read the news that's important to them. Your town has 1000's of activities going on every day, with many different viewpoints that make your town unique. On WikiXM, viewers can create articles, read, comment and contribute to other articles to bring out viewpoints that make your town unique. Our goal is to enable each town to gain full insight into every aspect of the news and topics that are impacting it. WikiXM is where civil conversation can be had and insight gained.
The WikiXM news platform promotes the local user audience to monitor the news in ways that fits each town's needs. The users monitor and help keep content civil by a flagging and rating system that promotes positive activity and demotes or removes negative activity.
We also promote those that initiate their towns WikiXM news site through our founder pages. The Founders are forever kept on the town's founder pages and are promoted on a frequent basis.
WikiXM promotes reporters that the town reads and rates highly. Reporters will be highlighted and given higher article ranking as they build their following and ranking. Reporters that achieve certain status levels will be given more privileges and greater status within their town's platform.
As WikiXM grows, articles will achieve higher levels of readership and geography. Whats discussed in one town may be important in others regardless of location. Our goal is to make our reporters rock stars!
There are a million interesting topics going on in your town today, report and discuss them on WikiXM. One day, the world may be following you.
The site is protected by reCAPTCHA
Town Requested
The site is protected by reCAPTCHA
The site is protected by reCAPTCHA
Welcome to , town news page.
The site is protected by reCAPTCHA
Welcome to WikiXM. Become the voice of your town.
Sign up as a reporter
The site is protected by reCAPTCHA